Panel Discussion - Eye Tracking in Healthcare and Medicine

Moderator

Dimitri A. Christakis
Director, Center for Child Health, Behavior and Development

Bio.: A pediatrician, researcher, and parent, Dimitri Christakis, is the George Adkins Professor of Pediatrics at the University of Washington, Director of the Center for Child Health, Behavior and Development at Seattle Children’s Research Institute, an attending pediatrician at Seattle Children’s Hospital, and editor in chief, JAMA Pediatrics. Professor Christakis graduated from Yale University and the University of Pennsylvania School of Medicine. He is the author of over 230 original research articles (h Index 93), a textbook of pediatrics and The Elephant in the Living Room: Make Television work for your kids. (September 2006; Rodale). In 2010 he was awarded the Academic Pediatric Association Research Award for outstanding contributions to pediatric research over his career. His passion is developing actionable strategies to optimize the cognitive, emotional, and social development of preschool children. The pursuit of that passion has taken him from the exam room, to the community and most recently to cages of newborn mice. Christakis’ laboratory focuses on the effects of early environmental influences on child health and development and his work has been featured on all major international news outlets as well as all major national and international newspapers. He speaks frequently to international audiences of pediatricians, parents, educators and policy makers about the impact of early learning on brain development. His eyes are exceedingly difficult to track.



Panelist

Roman Bednarik
Associate Professor at the School of Computing and Adjunct Professor of Interactive Technologies at University of Eastern Finland

Bio.: My interests lie in developing and applying robust eye tracking technologies and other sensors to create truly intelligent interactions and valid user state monitoring tools. Recently we applied these sensors in medical domains such as microsurgery, laparoscopy, and neurodegenerative disease diagnostics. Me and my research team built the first eye-tracker for surgical microscopes. Longterm, we are researching and developing sensorimotor technologies for clinical and professional users. I am also involved in commercialising of these technologies.



Panelist

Amanda Bentley
Senior Director of Sales and Business Development for Tobii’s Healthcare Solutions

Bio.: Amanda is currently the Senior Director of Sales and Business Development for Tobii’s Healthcare solutions. For the past decade, Amanda has worked with some of the world’s top research institutes, leading companies, and most inventive start-ups using eye tracking innovations to make the world a better place. With her extensive experience in visual behavior research and technical expertise of eye tracking solutions, she helps companies incorporate Tobii’s eye tracking technology into medical devices and healthcare applications. Amanda has advanced degrees in Research Psychology, where much of her work focused on advancing motivational theories for improving personal health.



Panelist

Katarzyna Chawarska
Emily Fraser Beede Professor of Child Psychiatry Director, Social and Affective Neuroscience of Autism Program, Child Study Center Director, Yale Toddler Developmental Disabilities Clinic

Bio.: Dr. Chawarska is the E. Frazer Beede Professor of Child Study, Pediatrics, and Statistics and Data Science at Yale School of Medicine and the Director of the Social and Affective Neuroscience of Autism (SANA) Program at the Child Study Center and the director of the Yale Autism Center of Excellence. She has been the principal investigator on numerous NIH-funded studies of infants at risk for ASD, as well as toddlers and preschoolers with neurodevelopmental disorders.Her research has been focused on improving the understanding of processes that give rise to core and comorbid features of autism. Much of this work has been implemented using eye-tracking methodology. Work from her lab identified some of the earliest attentional markers of autism in infancy, demonstrated continuity of the attentional vulnerabilities from prodromal into early syndromic stages of the disorder, and identified specific conditions under which attentional patterns of young children with autism diverge from those observed in control groups.



Panelist

Eakta Jain
Associate Professor of Computer and Information Science and Engineering at the University of Florida

Bio.: Eakta Jain is an Associate Professor of Computer and Information Science and Engineering at the University of Florida. She received her PhD and MS degrees in Robotics from Carnegie Mellon University and her B.Tech. degree from IIT Kanpur. She has industry experience at Texas Instruments R&D labs, Disney Research Pittsburgh, and the Walt Disney Animation Studios. Dr. Jain served as the Technical Program Chair for ACM Symposium on Eye Tracking Research (2020) and Applications and ACM/Eurographics Symposium on Applied Perception (2021). She currently leads the human factors group at the University of Florida Transportation Institute. Her research at the University of Florida has been funded through faculty research awards from Facebook/Oculus and Google/YouTube, the National Science Foundation, National Institutes of Health, and the Florida Department of Transportation. Dr. Jain is interested in user modeling and avatar generation, with particular interest and expertise in visual attention and eye tracking. Her recent publications on privacy risks created by large scale eye tracking have been presented at ETRA and IEEE VR, including a Best Paper nomination in 2021.



Panelist

Oleg Komogortsev
Professor of Computer Science at Texas State University / Bulbitech, Adivsor

Bio.: Dr. Komogortsev is currently a Professor of Computer Science at Texas State University and an advisor for Bulbitech. Dr. Komogortsev has received his B.S. in Applied Mathematics from Volgograd State University, and M.S./Ph.D. degree in Computer Science from Kent State University. He was previously a faculty or a scientist at such institutions as Johns Hopkins University, Notre Dame University, Michigan State University, and Meta. Dr. Komogortsev conducts research in eye tracking with a focus on health assessment, cyber security (biometrics), bioengineering, human computer interaction, and usability.
Dr. Komogortsev’s research was covered by the national media including NBC News, Discovery, Yahoo, Livesience and others. Dr. Komogortsev is a recipient of four Google and four Meta Faculty Research Awards. Dr. Komogortsev has also won National Science Foundation CAREER award and Presidential Early Career Award for Scientists and Engineers (PECASE) from President Barack Obama on the topic of cybersecurity with the emphasis on eye movement-driven biometrics and health assessment. In addition, his research was supported by the National Science Foundation, National Institute of Health, National Institute of Standards, Sigma Xi the Scientific Research Society, and various industrial sources. Dr. Komogortsev’s current grand vision is to push forward eye movement-driven user understanding with a very strong privacy backbone in the future virtual and augmented reality platforms.



Panelist

David Zee
Professor of Neurology, Johns Hopkins School of Medicine

Bio.: Dr. David Zee specializes in vertigo, dizziness and imbalance (including ataxia) and in disorders of eye movements (including nystagmus and strabismus). He is a Professor of Neurology at Johns Hopkins Medicine with secondary appointments in Otolaryngology-Head and Neck Surgery, Ophthalmology and Neuroscience. Dr. Zee’s many research interests include: applications of biomedical engineering to recording and analysis of eye movements both in normal subjects and in patients with neuro-ophthalmologic or vestibular disorders; the immediate visual and vestibular influences on eye movements and the more long-term adaptive processes that permit compensation for disease; and the use of eye movement recordings as diagnostic aids (for example, early diagnosis of stroke, multiple sclerosis, myasthenia gravis).